Alfred Geissele, MD
Orthopaedic Surgery · Hickory, NCNPI 1902858863
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $10,100 of the $13,294 with a category attached, or 76.0%. Si-bone, Inc. accounts for 78.8% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2019 at $5,703 and has fallen 97.6% since, to $138 in 2025.
Across 58 payments — averaging $229.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Si-bone, Inc.$10K
- Medtronic$2K
- Boston Scientific$775
- Collegium Pharmaceutical, Inc.$93
- Orthofix Medical, Inc.$67
- Abbott$34
- plus $53 from 3 others
What the payments were for
- Consulting fees$10,10076%
- Travel & lodging$1,46011%
- Food & beverage$1,73313%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Si-bone, Inc. | 13 | $10,469 |
| Medtronic | 25 | $1,802 |
| Boston Scientific | 5 | $775 |
| Collegium Pharmaceutical, Inc. | 6 | $93 |
| Orthofix Medical, Inc. | 4 | $67 |
| Abbott | 2 | $34 |
| Vertex | 1 | $20 |
| Pacira Therapeutics, Inc. | 1 | $18 |
| Hospira, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- iFuse Implant$10,259
- MAZOR X SYSTEM$1,088
- Superion Indirect Decompression System$571
How this compares
$13,294 in reported general payments places this provider in the 70th percentile of 845 orthopaedic surgery providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Etodolac | 124 | $4,384 |
| Diclofenac Sodium | 417 | $3,869 |
| Meloxicam | 911 | $3,046 |
| Celecoxib | 140 | $2,852 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 63 | $1,134 |
| Gabapentin | 67 | $869 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 30 | $631 |
| Nabumetone | 55 | $536 |
| Sulindac | 55 | $513 |
| Tizanidine Hcl | 78 | $431 |
| Pregabalin | 18 | $340 |
| Tramadol Hcl | 33 | $139 |
| Cyclobenzaprine Hcl | 15 | $86 |
| Baclofen | 11 | $63 |
| Methylprednisolone | 13 | $54 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Hickory
- Thomas FehringCharlotte$18.3M
- Walter BeaverCharlotte$7.4M
- Robert AndersonCharlotte$6.6M
- William JiranekDurham$6.4M
- John MasonCharlotte$5.7M
- Thomas VailDurham$5.7M
- William DavisCharlotte$5.2M
- John EllingtonCharlotte$4.9M
- Mark EasleyDurham$4M
- Carroll JonesCharlotte$3.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.